Patents by Inventor Jürgen Eck
Jürgen Eck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230084263Abstract: The present invention relates to ingredients, particularly sweetening ingredients, for example ingredients for use in reduced sugar, low-sugar, or zero-sugar beverage or food products. More specifically, the present invention relates to ingredients derived from plant infusions, in particular fermented infusions of stevia.Type: ApplicationFiled: February 15, 2021Publication date: March 16, 2023Inventors: Alice CANCELLIERI, Zafer GEZGIN, Paul Stephen JONES, Caroline Jane SAUNDERS, Roberto VANIN, Juergen ECK, Guido MEURER, Claudia BORGMEIER
-
Patent number: 10889785Abstract: Formulations, compositions and products for reducing allergenic Fel d 1 from the environment are disclosed. The formulations include at least one protease that interacts with the Fel d 1 and substantially degrades allergenic epitopes on the Fel d 1. Methods of using the formulations for reducing or eliminating allergenic Fel d 1 from the environment are also disclosed.Type: GrantFiled: April 4, 2018Date of Patent: January 12, 2021Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.Inventors: George Wells, Delphine Tissot-Favre, Ebenezer Satyaraj, Juergen Eck, Daniel Meyer, Torsten Ertongur-Fauth, Alexander Pelzer, Scott Sherrill, Peichuan Sun
-
Publication number: 20180223223Abstract: Formulations, compositions and products for reducing allergenic Fel d 1 from the environment are disclosed. The formulations include at least one protease that interacts with the Fel d 1 and substantially degrades allergenic epitopes on the Fel d 1. Methods of using the formulations for reducing or eliminating allergenic Fel d 1 from the environment are also disclosed.Type: ApplicationFiled: April 4, 2018Publication date: August 9, 2018Inventors: George Wells, Delphine Tissot-Favre, Ebenezer Satyaraj, Juergen Eck, Daniel Meyer, Torsten Ertongur-Fauth, Alexander Pelzer, Scott Sherrill, Peichuan Sun
-
Publication number: 20180016543Abstract: A method of producing yeast mutants and the use thereof. In order to provide yeasts which, at a given sugar content, produce a low ethanol content and a relatively high glycerol content in ethanolic fermentation and which are simultaneously obtainable rapidly, at least one yeast strain is contacted in a first mutagenesis step with a first mutagen and in a second mutagenesis step with a second mutagen. The first and second mutagens are different from one another and are selected from the following groups: nucleotide-alkylating agent, nucleotide-deaminating agent, and UV radiation. The method further includes a first selection step executed between the first and second mutagenesis steps and a second selection step being executed after the second mutagenesis step, in which the mutants that originate from the prior mutagenesis step in each case are exposed to a selection factor selected from the following groups: (a) hypertonic medium and (b) alcohol dehydrogenase inhibitor.Type: ApplicationFiled: February 4, 2016Publication date: January 18, 2018Applicants: Erbslöh Geisenheim AG, BRAIN AGInventors: Jürgen FRÖHLICH, Jürgen ECK, Guido MEURER, Christian NAUMER, Jörg BÜSCHER, Jörg MAMPEL
-
Patent number: 9353386Abstract: The present invention relates to a host cell having an elevated expression or activity of an enzyme as compared with the parent cell from which it has been derived, said enzyme having lactoyl-CoA reductase activity. Furthermore, provided is a method of producing lactaldehyde and/or 1,2-propanediol, said method comprising culturing said host cell and/or utilizing said enzyme to produce said compound.Type: GrantFiled: June 15, 2012Date of Patent: May 31, 2016Assignee: B.R.A.I.N. Biotechnology Research and Information Network AGInventors: Daniel Koch, Guido Meurer, Jürgen Eck
-
Patent number: 9193961Abstract: The present invention relates to a polynucleotide encoding an enzyme having carboxylesterase [E.C.3.1.1.1] activity.Type: GrantFiled: May 3, 2007Date of Patent: November 24, 2015Assignee: B.R.A.I.N. AGInventors: Klaus Liebeton, Jürgen Eck, Uwe Bornscheuer, Dominique Böttcher, Peter Langer, Esen Bellur
-
Publication number: 20150175940Abstract: Formulations, compositions and products for reducing allergenic Fel d 1 from the environment are disclosed. The formulations include at least one protease that interacts with the Fel d 1 and substantially degrades allergenic epitopes on the Fel d 1. Methods of using the formulations for reducing or eliminating allergenic Fel d 1 from the environment are also disclosed.Type: ApplicationFiled: December 15, 2014Publication date: June 25, 2015Inventors: George Wells, Delphine Tissot-Favre, Ebenezer Satyaraj, Juergen Eck, Daniel Meyer, Torsten Ertongur-Fauth, Alexander Pelzer, Scott Sherrill, Peichuan Sun
-
Patent number: 8993743Abstract: The present invention relates to a nucleic acid molecule encoding a chimeric protein having the biochemical activity of a surface active protein, wherein said chimeric protein comprises: (a) an N-terminal portion of a first surface active protein, wherein the N-terminal portion is devoid of between 0 and 10 of the most N-terminal amino acids of the mature first surface active protein; and, C-terminally thereof, (b) a C-terminal portion of a second surface active protein, wherein the C-terminal portion is devoid of between 0 and 10 of the most C-terminal amino acids of the mature second surface active protein. The present invention further relates to a vector, a non-human host and a method for the production of a chimeric protein having the biochemical activity of a surface active protein. In addition, the present invention relates to a chimeric protein encoded by the nucleic acid molecule of the invention and a composition comprising the chimeric protein.Type: GrantFiled: February 18, 2011Date of Patent: March 31, 2015Assignee: B.R.A.I.N. Biotechnology Research and Information Network AGInventors: Guido Meurer, Esther Gabor, Anke Bachert, Jürgen Eck
-
Patent number: 8790900Abstract: The invention relates to the biotechnological production of isomaltulose and isomaltulose-containing compositions and improved means, therefore particularly microbial cells.Type: GrantFiled: October 23, 2010Date of Patent: July 29, 2014Assignee: Südzucker Aktiengesellschaft Mannheim/OchsenfurtInventors: Stefan Pelzer, Christian Zurek, Thomas Rose, Jürgen Eck, Wolfgang Wach, Michael Klingeberg, Karsten Harms
-
Publication number: 20140178953Abstract: The present invention relates to a host cell having an elevated expression or activity of an enzyme as compared with the parent cell from which it has been derived, said enzyme having lactoyl-CoA reductase activity. Furthermore, provided is a method of producing lactaldehyde and/or 1,2-propanediol, said method comprising culturing said host cell and/or utilizing said enzyme to produce said compound.Type: ApplicationFiled: June 15, 2012Publication date: June 26, 2014Applicant: B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AGInventors: Daniel Koch, Guido Meurer, Jürgen Eck
-
Patent number: 8691535Abstract: For the biotechnological production of isomaltulose and compositions containing isomaltulose from saccharose the invention provides improved means, particularly a sucrose mutase with improved product specificity as well as microbial cells containing the improved sucrose mutase.Type: GrantFiled: December 18, 2010Date of Patent: April 8, 2014Assignee: Südzucker Aktiengesellschaft Mannheim/OchsenfurtInventors: Wolfgang Aehle, Juergen Eck, Karsten Harms, Michael Klingeberg, Stefan Pelzer, Wolfgang Wach
-
Patent number: 8679829Abstract: The present invention relates to a sulfolobus expression vector comprising: (a) sulfolobus origin of replication; (b) the genes encoding the structural proteins and the site-specific integrase of SSV1, SSV2 or pSSVx, operatively linked to expression control sequences and a packaging signal; (c) one or more selectable marker gene(s), operatively linked to sulfolobus expression control sequences; and (d) a sulfolobus promoter followed 3? by a restriction enzyme recognition site or a multiple cloning site for insertion of a gene of interest and optionally a 3? regulatory element. Moreover, the present invention relates to a shuttle vector comprising the sequences of the expression vector of the invention and additional sequences for propagation and selection in E. coli, wherein the additional sequences comprise (a) an E. coli on of replication; and (b) a marker for selection in E. coli.Type: GrantFiled: June 2, 2004Date of Patent: March 25, 2014Assignee: B.R.A.I.N. Biotechnology Research and Information Network AGInventors: Christa Schleper, Melanie Jonuscheit, Jürgen Eck, Frank Niehaus, Sonja-Verena Albers, Sabrina Froels
-
Patent number: 8623810Abstract: We have identified by molecular cloning a protease which originates from the larvae of Lucilia sericata and which was termed debrilase due to its activities useful for debridement of wounds.Type: GrantFiled: March 3, 2010Date of Patent: January 7, 2014Assignee: B.R.A.I.N. Biotechnology Research and Information Network AGInventors: Frank Niehaus, Jürgen Eck, Renate Schulze, Michael Krohn
-
Patent number: 8470576Abstract: The present invention provides a polynucleotide or a pair of polynucleotides encoding an enzyme having nitrile hydratase (NHase) [E.C. 4.2.1.84] activity. Furthermore, a vector and a host comprising the disclosed polynucleotide or pair of polynucleotides and methods for the production of the same are provided. Moreover, the invention relates to a pair of polypeptides or a fusion protein having NHase activity, an antibody specifically binding to the pair of polypeptides or fusion protein, a primer or probe, which specifically hybridizes under stringent conditions to the disclosed polynucleotide or either one of the pair of polynucleotides, a composition comprising the polynucleotide or pair of polynucleotides, the pair of polypeptides or fusion protein, the antibody and/or one or more primers or probes of the invention and a method for the production of amides comprising the enantioselective conversion of nitriles.Type: GrantFiled: April 5, 2007Date of Patent: June 25, 2013Assignee: B.R.A.I.N. AGInventors: Jürgen Eck, Klaus Liebeton, Lutz Fischer, Sabine Lutz-Wahl, Martina Hensel, Christian Ewert, Marcus Wälz
-
Patent number: 8455107Abstract: By treatment with hydrophobins, cellulosic materials such as paper, cardboard, cotton or, especially, wood-based materials, such as solid wood, glued wood products or particle board, can be effectively protected against absorption of and attack by water and/or moisture.Type: GrantFiled: February 27, 2008Date of Patent: June 4, 2013Assignee: BASF SEInventors: Esther Gabor, Andreas Buthe, Jürgen Eck, Franz Kaufmann, Hans-Jörg Koch, Guido Meurer
-
Publication number: 20120315673Abstract: For the biotechnological production of isomaltulose and compositions containing isomaltulose from saccharose the invention provides improved means, particularly a sucrose mutase with improved product specificity as well as microbial cells containing the improved sucrose mutase.Type: ApplicationFiled: December 18, 2010Publication date: December 13, 2012Inventors: Wolfgang Aehle, Juergen Eck, Karsten Harms, Michael Klingeberg, Stefan Pelzer, Wolfgang Wach
-
Publication number: 20120225458Abstract: The invention relates to the biotechnological production of isomaltulose and isomaltulose-containing compositions and improved means, therefore particularly microbial cells.Type: ApplicationFiled: October 23, 2010Publication date: September 6, 2012Applicant: SUDZUCKER AKTIENGESELLSCHAFT MANNHEIM/OCHSENFURTInventors: Stefan Pelzer, Christian Zurek, Thomas Rose, Jürgen Eck, Wolfgang Wach, Michael Klingeberg, Karsten Harms
-
Publication number: 20120213764Abstract: The present invention relates to a method of producing a peptide consisting of the amino acids 63 to 110 of dermcidin (SEQ ID NO: 3) comprising (a) culturing a host cell carrying a nucleic acid molecule encoding the peptide in an expressible form, and (b) optionally isolating the peptide from the culture. Furthermore, the invention relates to a nucleic acid molecule encoding a fusion protein comprising or consisting of (a) a peptide heterologous with regard to dermcidin protein-tag; and, C-terminally thereof (b) a peptide having the antimicrobial activity of dermcidin wherein the fusion protein contains an arginine residue located immediately N-terminally of the peptide of (b).Type: ApplicationFiled: September 22, 2010Publication date: August 23, 2012Applicant: B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AGInventors: Christian Naumer, Michael Krohn, Yvonne Tiffert, Jürgen Eck
-
Patent number: 8226967Abstract: The invention relates to a use of surface active hydrophobins for applications in pharmaceutical technology, in particular as excipients for galenic use. Provided is a method for either admixture of hydrophobins to galenic compositions or for treating the surface of pharmaceutical forms with a hydrophobin-containing solution to modify the pharmaceutical properties of the galenic form. In a preferred embodiment of the invention hydrophobins are used to improve the properties of a pharmaceutical composition, e.g. to act as a surfactant or to increase resistance to disintegration of the galenic forms to achieve a retarded drug release. The galenic form to be modified by the use of surface active proteins as excipients can be capsules, tablets, pills, microparticles, vesicles, and suppositories, although further galenic forms are envisioned.Type: GrantFiled: November 13, 2009Date of Patent: July 24, 2012Assignee: BASF SEInventors: Andreas Buthe, Andreas Hafner, Franz Kaufmann, Esther Gabor, Guido Meurer, Jürgen Eck, Gordon Bradley
-
Patent number: RE47528Abstract: We have identified by molecular cloning a protease which originates from the larvae of Lucilia sericata and which was termed debrilase due to its activities useful for debridement of wounds.Type: GrantFiled: January 25, 2018Date of Patent: July 23, 2019Assignee: B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AGInventors: Frank Niehaus, Jürgen Eck, Renate Schulze, Michael Krohn